Status:
RECRUITING
Ketorolac Use and Fresh Embryo Transfer Outcomes
Lead Sponsor:
Jessica D. Kresowik
Conditions:
Infertility (IVF Patients)
Infertility Treatment
Eligibility:
FEMALE
18-37 years
Phase:
PHASE4
Brief Summary
Ketorolac is a medication often used to relieve pain after surgery. In the past, infertility doctors have been cautious about using ketorolac after egg retrieval for patients planning a fresh embryo t...
Detailed Description
Study Design: double-blind randomized controlled trial Intervention: Ketorolac (30mg intravenous) administration in the immediate post-operative period prior to leaving the procedure room and while pa...
Eligibility Criteria
Inclusion
- IVF utilizing autologous oocytes and all sperm sources
- IVF cycles utilizing ICSI and standard insemination
- Plan to transfer embryo on day 5
- BMI below 50
Exclusion
- allergies or medical contraindications to NSAIDs
Key Trial Info
Start Date :
November 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07185724
Start Date
November 8 2025
End Date
September 1 2028
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UI Health Care Center for Advanced Reproductive Care
Iowa City, Iowa, United States, 52245